Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Upper Tract Urothelial Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Not applicableLooking for participantsNCT07614594
What this trial is testing

Non-invasive Urinary Genomics-Based Risk Assessment for Early Urothelial Carcinoma Diagnosis

Who this might be right for
Urothelial Carcinoma (UC)Upper Tract Urothelial CarcinomaUTUC+1 more
Henan Provincial People's Hospital 800
Not applicableActive Not RecruitingNCT06805630
What this trial is testing

Urine Methylation Markers in UTUC

Who this might be right for
Upper Tract Urothelial Cancer
Duke University 50
Early research (Phase 1)Not Yet RecruitingNCT05979909
What this trial is testing

Intravesical Mitomycin C After Diagnostic Ureteroscopy for Upper Tract Urothelial Carcinoma

Who this might be right for
Urothelial Carcinoma UreterUrothelial Cancer of Renal Pelvis
McMaster University 40
Early research (Phase 1)Looking for participantsNCT07492628
What this trial is testing

Dual-Target Nectin-4/HER2 CAR-NK Cells in Advanced Urothelial Carcinoma

Who this might be right for
Bladder CancerUrothelial CarcinomaMetastatic Urothelial Carcinoma+2 more
Beijing Biotech 42
Not applicableStudy completedNCT06401265
What this trial is testing

Recalling the Treatment and Prognosis of Upper Tract Urothelial Cancer (UTUC)

Who this might be right for
Uterine Cancer
Taipei Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation 8,000
Testing effectiveness (Phase 2)Looking for participantsNCT05917158
What this trial is testing

RC48-ADC Combined with JS001 for Postoperative Adjuvant Treatment of Upper Tract Urothelial Carcinoma

Who this might be right for
CarcinomaUpper Tract Urothelial CarcinomaUTUC
Jinling Hospital, China 30
Testing effectiveness (Phase 2)Looking for participantsNCT06356155
What this trial is testing

Study of Neoadjuvant Enfortumab Vedotin and Pembrolizumab in Upper Tract Urothelial Cancer

Who this might be right for
Urothelial Carcinoma
University of Michigan Rogel Cancer Center 32
Large-scale testing (Phase 3)UnknownNCT01993979
What this trial is testing

A Phase III Randomised Trial of Peri-Operative Chemotherapy Versus sUrveillance in Upper Tract Urothelial Cancer (POUT)

Who this might be right for
Transitional Cell Carcinoma of Ureter
Institute of Cancer Research, United Kingdom 261
Not applicableLooking for participantsNCT06116396
What this trial is testing

Liquid Biospy for Urinary Cancers

Who this might be right for
Urothelial Carcinoma
IRCCS San Raffaele 450
Testing effectiveness (Phase 2)Active Not RecruitingNCT05868265
What this trial is testing

Enfortumab Vedotin in People With Urothelial Carcinoma of the Upper Urinary Tract

Who this might be right for
Urothelial Carcinoma
Memorial Sloan Kettering Cancer Center 9
Testing effectiveness (Phase 2)Looking for participantsNCT06948552
What this trial is testing

Photodynamic Diagnosis of Upper Tract Urothelial Carcinoma Using Fluorescence Endoscopy and Oral 5-ALA

Who this might be right for
Upper Tract Urothelial Carcinoma
Henry Ford Health System 10
Large-scale testing (Phase 3)Study completedNCT02793128
What this trial is testing

The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study

Who this might be right for
Carcinoma, Transitional CellTransitional Cell Carcinoma of Renal Pelvis
UroGen Pharma Ltd. 71
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07827612
What this trial is testing

Vepugratinib (LY3866288) in Adults With Non-Muscle Invasive Bladder Cancer and Upper Tract Urothelial Cancer

Who this might be right for
Urinary Bladder NeoplasmsUrologic NeoplasmsReceptor, Fibroblast Growth Factor, Type 3
Eli Lilly and Company 161
Testing effectiveness (Phase 2)Study completedNCT03693612
What this trial is testing

GSK3359609 Plus Tremelimumab for the Treatment of Advanced Solid Tumors

Who this might be right for
Neoplasms
GlaxoSmithKline 26
Testing effectiveness (Phase 2)UnknownNCT04099589
What this trial is testing

Neoadjuvant Treatment of Upper Urinary and Muscular Invasive Bladder Urothelial Carcinoma

Who this might be right for
Upper Tract Urinary CarcinomaMuscle-invasive Bladder Cancer
Cancer Institute and Hospital, Chinese Academy of Medical Sciences 64
Testing effectiveness (Phase 2)Active Not RecruitingNCT03333616
What this trial is testing

Nivolumab Combined With Ipilimumab for Patients With Advanced Rare Genitourinary Tumors

Who this might be right for
Genitourinary CancerAdrenocortical CarcinomaNon-urothelial Bladder+5 more
Dana-Farber Cancer Institute 100
Not applicableLooking for participantsNCT06218433
What this trial is testing

Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)

Who this might be right for
Urothelial CarcinomaLynch Syndrome
Tampere University Hospital 200
Post-approval studies (Phase 4)Looking for participantsNCT06820255
What this trial is testing

DDR Genes Alteration and Response to Platinum-based Chemotherapy in Advanced Urothelial Cancer.

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Metastatic or UnresectableUpper Tract Urothelial Cancer
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 135
Not applicableStudy completedNCT02326909
What this trial is testing

Diagnostic Accuracy of Optical Coherence Tomography in Upper Urinary Tract Urothelial Carcinoma

Who this might be right for
Transitional Cell Carcinoma of Urinary Tract
Academisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA) 26
Testing effectiveness (Phase 2)Study completedNCT01031420
What this trial is testing

Dose Dense MVAC for Muscle Invasive Bladder Cancer

Who this might be right for
Muscle Invasive Bladder CancerHigh Risk Urothelial Carcinoma of the Upper Urinary Tracts
Fox Chase Cancer Center 54
Next Page